 |
This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this articlebyintroducing citations to additional sources.
Find sources: "4-Bromo-3,5-dimethoxyamphetamine" – news · newspapers · books · scholar · JSTOR (September 2019) |
| |
| |
| Names | |
|---|---|
| Preferred IUPAC name
1-(4-Bromo-3,5-dimethoxyphenyl)propan-2-amine | |
| Other names
4-Bromo-3,5-dimethoxyamphetamine | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider |
|
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C11H17BrNO2 | |
| Molar mass | 275.166 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
4-Bromo-3,5-dimethoxyamphetamine is a lesser-known psychedelic drug and a substituted amphetamine. It was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 4–10 mg and the duration is listed as 8–12 hours.[1] It produces analgesia, numbness, and reduction of physical feeling. Very little data exists about its pharmacological properties, metabolism, and toxicity.
 | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |
